Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarkers in Immuno-Oncology | Whitepapers & Reports

Enabling Ultrasensitive Protein Quantification with the Quanterix Homebrew Kit

22 November 2022
Unique Homebrew Kits give researchers the flexibility to develop custom Simoa assays.

Quanterix™ has developed an ultrasensitive platform capable of measuring individual proteins at concentrations 1,000 times lower than standard immunoassays. The Single Molecule Array (Simoa®) technology at the heart of this platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening new applications to address significant unmet needs in life science research.

Together, the Simoa Homebrew Kit, the Homebrew Assay Development Guide, and the Simoa HD-X Analzyer provide a powerful and unique combination of reagents, guided instruction, cutting-edge digital immunoassay technology, full automation, and open access tools to maximize efficiency and productivity in ultra-high sensitivity immunoassay-enabled research.

View Content

Related Resources

New Multi-Omic AI-Driven Initiative for Immuno-Oncology Biomarker Development

The team aims to establish a consortium of cancer centres to join the project of developing biomarkers from multi-omic analysis.
Read More

Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology

Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Read More